GB1588201A - Medicinal compositions - Google Patents

Medicinal compositions Download PDF

Info

Publication number
GB1588201A
GB1588201A GB2617/78A GB261778A GB1588201A GB 1588201 A GB1588201 A GB 1588201A GB 2617/78 A GB2617/78 A GB 2617/78A GB 261778 A GB261778 A GB 261778A GB 1588201 A GB1588201 A GB 1588201A
Authority
GB
United Kingdom
Prior art keywords
composition according
composition
fluoride
thiomucase
theophylline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2617/78A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOLZMANN D
Original Assignee
HOLZMANN D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOLZMANN D filed Critical HOLZMANN D
Publication of GB1588201A publication Critical patent/GB1588201A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A61K8/21—Fluorides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB2617/78A 1977-01-24 1978-01-23 Medicinal compositions Expired GB1588201A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7701900A FR2377805A1 (fr) 1977-01-24 1977-01-24 Nouvelle composition en particulier pour le traitement de la cellulite

Publications (1)

Publication Number Publication Date
GB1588201A true GB1588201A (en) 1981-04-15

Family

ID=9185828

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2617/78A Expired GB1588201A (en) 1977-01-24 1978-01-23 Medicinal compositions

Country Status (9)

Country Link
US (1) US4191748A (cg-RX-API-DMAC7.html)
BE (1) BE863085A (cg-RX-API-DMAC7.html)
CA (1) CA1100405A (cg-RX-API-DMAC7.html)
CH (1) CH627650A5 (cg-RX-API-DMAC7.html)
DE (1) DE2802363A1 (cg-RX-API-DMAC7.html)
FR (1) FR2377805A1 (cg-RX-API-DMAC7.html)
GB (1) GB1588201A (cg-RX-API-DMAC7.html)
IT (1) IT1093259B (cg-RX-API-DMAC7.html)
NL (1) NL7800785A (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490492A1 (fr) * 1980-09-22 1982-03-26 Riker Laboratories Inc Composition cosmetique pour le traitement local de la cellulite
FR2639541B1 (fr) * 1988-11-29 1993-09-24 Fabre Pierre Cosmetique Amincissants topiques contenant des derives cafeines carboxyliques neutralises par des bases organiques et preparations utiles dans le traitement de la cellulite
US5102783A (en) * 1990-01-12 1992-04-07 Vetrepharm, Inc. Composition and method for culturing and freezing cells and tissues
DE19901502C1 (de) * 1999-01-11 2000-09-21 Michael Schneider Anticellulitiszusammensetzung und ihre Verwendung
CA2915814A1 (en) 2013-06-18 2014-12-24 Harrow Ip, Llc Local use of pentoxifylline to treat peyronie's disease
US10383875B2 (en) 2013-06-18 2019-08-20 Harrow Ip, Llc Pharmaceutical formulations of xanthine or xanthine derivatives, and their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976212A (en) * 1956-12-01 1961-03-21 Schenley Ind Inc Hyaluronidase with heparin or heparinoids in ointment compositions
US3978213A (en) * 1972-07-10 1976-08-31 Nelson Research & Development Company Cosmetic use of cyclic amp and phosphodiesterase inhibitors

Also Published As

Publication number Publication date
US4191748A (en) 1980-03-04
NL7800785A (nl) 1978-07-26
DE2802363C2 (cg-RX-API-DMAC7.html) 1987-10-15
IT1093259B (it) 1985-07-19
DE2802363A1 (de) 1978-07-27
FR2377805A1 (fr) 1978-08-18
CH627650A5 (fr) 1982-01-29
CA1100405A (en) 1981-05-05
FR2377805B1 (cg-RX-API-DMAC7.html) 1979-05-11
BE863085A (fr) 1978-07-19
IT7819537A0 (it) 1978-01-23

Similar Documents

Publication Publication Date Title
Charles et al. Insulin secretion. Interrelationships of glucose, cyclic adenosine 3: 5-monophosphate, and calcium.
Silinsky et al. Biological sciences: Release of ATP from rat motor nerve terminals
US4424232A (en) Treatment of herpes simplex
JPS646216A (en) Therapy for abstinence symptom related to no smoking and medicine therefor
KR920002330B1 (ko) 주석 프로토포르피린 또는 주석 메조포르피린을 함유하는 건선 치료용 제약 조성물
US4191748A (en) Novel medicinal composition, especially for the treatment of cellulitis
CA1226524A (en) Pharmaceutical composition for the treatment of hair loss
Kitabchi et al. Steroidogenesis in isolated adrenal cells of rat: II. Effect of caffeine on ACTH and cyclic nucleotide-induced steroidogenesis and its relation to cyclic nucleotide phosphodiesterase (PDE)
Rigalli et al. Comparative study of the effect of sodium fluoride and sodium monofluorophosphate on glucose homeostasis in the rat
Peters et al. Some biochemical effects of triamcinolone acetonide on rat liver and muscle
WO1992006700A1 (en) Topical preparation and method for suppression of skin eruptions caused by herpes simplex virus
US4699777A (en) Compositions and method for enhancement of the transdermal flux of albuterol with a combination of 1-dodecyl-azacyclopheptan-2-one and urea
ES8700054A1 (es) Procedimiento de obtencion de germicidas a base de acidos clorhidrico y fosforico.
EP0137807A1 (en) Antiviral composition and method for administering the same
Andén et al. Does treatment with haloperidol for 3 weeks produce depolarization block in midbrain dopamine neurons of unanaesthetized rats?
ES8706027A1 (es) Procedimiento de obtencion de una composicion para el tratamiento de vitiligo
Goodman Metabolic effects of imidazole in adipose tissue
EP0105448A1 (en) The use of undecylenic acid for the manufacture of a composition for the treatment of Herpes labialis
Tipnis et al. Protein and lipid content of Chlorella vulgaris in relation to light
Rosenberg et al. Stimulation of rat liver adenylate cyclase by halothane
Pan et al. Intermittent treatments of prostaglandin E2 plus risedronate and prostaglandin E2 alone are equally anabolic on tibial shaft of ovariectomized rats
JPS6479105A (en) Powder composition for beauty culture pack of occasion preparation type
USRE32990E (en) Use of undercylenic acid to treat herpes labialis
US2653901A (en) Adenylic acid salts-gelatin composition
US5348981A (en) Antiherpetic treatment

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee